Market Overview The angina market is experiencing pharmacotherapy emphasis where beta-blockers, calcium channel blockers, nitrates, and novel agents enable comprehensive symptom control and ischemia prevention. The angina market is projected to exceed USD 9.2 billion through 2030, with pharmacotherapy emphasis driven by medication efficacy, ease of use, and first-line status. Antianginal...